Fierce Healthcare May 13, 2022
Ralph Pisano

The stigma of mental health disorders is slowly disappearing, and that’s a very good thing. You see evidence of this everywhere: on TV and social media, in ad reads on podcasts, even in the traditionally don’t-show-weakness world of professional sports. There is growing acceptance of discussions around mental health.

Unfortunately, despite this cultural change, the prevalence of mental health disorders appears to be increasing, and well-known examples of its unfortunate consequences are all too common.

Medication is a huge part of maintaining mental health for millions of Americans, but clearly the pharmaceutical industry is facing challenges in addressing this problem. I see three main obstacles to progress: adherence, cost and innovation.

Adherence interference

Non-adherence to medication is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mental Health, Pharma, Pharma / Biotech, Provider
Podcast: Amy Stiffarm on Supporting Perinatal Mental Health Within Indigenous Communities
‘Investors Are Hungry To Find the Best’: It’s Feast or Famine in Digital Behavioral Health Investing
ABA Provider NeurAbilities Healthcare’s CEO Katheleen Stengel Resigns
Therapeutic Relationship Plays Key Role in Psychedelic Treatment
CEO of KKR-Backed Autism Provider BlueSprig Steps Down

Share This Article